Therapeutic strategies in prostate cancer

Prostate cancer accounts for nearly a quarter of all male cancers, and the incidence is rising as detection rates continue to improve, and life expectancy increases. Timely intervention affords a wider range of management options and in this new volume of Therapeutic Strategies in Prostate Cancer by Dr Heather Payne and Dr Mark Feneley, the choices available are reviewed.

Key topics discussed include the effectiveness of PSA screening, current prognostic models in predicting clinical outcomes, the role of biomarkets in evaluating therapeutic success, how to determine the endpoint of clinical trials, as well as looking forward to new horizons in chemotherapy.

Back to →

Comments are closed.